Avadel Pharmaceuticals (AVDL) Total Debt: 2009-2022
Historic Total Debt for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Sep 2022 value amounting to $136.2 million.
- Avadel Pharmaceuticals' Total Debt fell 4.12% to $136.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $136.2 million, marking a year-over-year decrease of 4.12%. This contributed to the annual value of $142.4 million for FY2021, which is 11.07% up from last year.
- Avadel Pharmaceuticals' Total Debt amounted to $136.2 million in Q3 2022, which was up 1.43% from $134.3 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Total Debt registered a high of $142.7 million during Q1 2022, and its lowest value of $1.9 million during Q2 2020.
- Over the past 3 years, Avadel Pharmaceuticals' median Total Debt value was $136.2 million (recorded in 2022), while the average stood at $114.2 million.
- In the last 5 years, Avadel Pharmaceuticals' Total Debt slumped by 92.11% in 2020 and then surged by 7,307.21% in 2021.
- Avadel Pharmaceuticals' Total Debt (Quarterly) stood at $125.2 million in 2018, then increased by 1.65% to $127.2 million in 2019, then grew by 0.76% to $128.2 million in 2020, then grew by 11.07% to $142.4 million in 2021, then fell by 4.12% to $136.2 million in 2022.
- Its last three reported values are $136.2 million in Q3 2022, $134.3 million for Q2 2022, and $142.7 million during Q1 2022.